ArticleExperimental and therapeutic medicine2023

Diosgenin alleviates the inflammatory damage and insulin resistance in high glucose‑induced podocyte cells via the AMPK/SIRT1/NF‑κB signaling pathway.

Haoyu Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.